Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System.
Ângela Jornada BenJeruza L NeyeloffCamila F de SouzaAna Paula O RossesAline L de AraujoAdriana SzortikaFranciele LocatelliGabriela de CarvalhoCristina R NeumannPublished in: Applied health economics and health policy (2020)
Systematic teleophthalmology-based DR screening for the Brazilian population with T2D would be considered very cost effective compared to the opportunistic ophthalmology referral-based screening according to the WHO-WTP threshold. However, there is still a considerable amount of uncertainty around the results.